Patton Albertson Miller Group LLC decreased its position in Mylan N.V. (NASDAQ:MYL) by 29.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,418 shares of the company’s stock after selling 2,622 shares during the period. Patton Albertson Miller Group LLC’s holdings in Mylan N.V. were worth $248,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cleararc Capital Inc. boosted its stake in Mylan N.V. by 0.6% in the first quarter. Cleararc Capital Inc. now owns 10,394 shares of the company’s stock valued at $405,000 after buying an additional 67 shares in the last quarter. Conning Inc. boosted its stake in Mylan N.V. by 1.3% in the first quarter. Conning Inc. now owns 10,128 shares of the company’s stock valued at $395,000 after buying an additional 130 shares in the last quarter. Sei Investments Co. boosted its stake in Mylan N.V. by 1.0% in the first quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock valued at $541,000 after buying an additional 134 shares in the last quarter. Bank of Nova Scotia boosted its stake in Mylan N.V. by 1.9% in the first quarter. Bank of Nova Scotia now owns 10,525 shares of the company’s stock valued at $410,000 after buying an additional 196 shares in the last quarter. Finally, Wade G W & Inc. boosted its stake in Mylan N.V. by 3.6% in the first quarter. Wade G W & Inc. now owns 6,156 shares of the company’s stock valued at $240,000 after buying an additional 213 shares in the last quarter. 70.19% of the stock is currently owned by institutional investors and hedge funds.

Mylan N.V. (MYL) opened at 32.29 on Friday. The stock’s 50 day moving average is $37.57 and its 200 day moving average is $39.05. Mylan N.V. has a 52-week low of $29.58 and a 52-week high of $49.42. The company has a market cap of $17.28 billion, a price-to-earnings ratio of 26.10 and a beta of 1.27.

Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.08. The company had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The firm’s revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.16 earnings per share. On average, analysts predict that Mylan N.V. will post $4.68 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/patton-albertson-miller-group-llc-sells-2622-shares-of-mylan-n-v-nasdaqmyl/1474668.html.

Several research firms recently issued reports on MYL. Royal Bank Of Canada set a $41.00 price target on shares of Mylan N.V. and gave the company a “hold” rating in a report on Saturday, May 13th. Cantor Fitzgerald set a $34.00 price target on shares of Mylan N.V. and gave the company a “hold” rating in a report on Wednesday. Cowen and Company reaffirmed a “hold” rating and issued a $30.00 price target (down from $43.00) on shares of Mylan N.V. in a report on Wednesday. UBS AG reaffirmed a “buy” rating and issued a $46.00 price target (down from $50.00) on shares of Mylan N.V. in a report on Thursday. Finally, BMO Capital Markets reaffirmed an “outperform” rating and issued a $45.00 price target (down from $50.00) on shares of Mylan N.V. in a report on Thursday. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $47.83.

In related news, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the completion of the transaction, the insider now directly owns 140,653 shares of the company’s stock, valued at $5,626,120. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the transaction, the president now directly owns 799,855 shares of the company’s stock, valued at $31,994,200. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by company insiders.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.